Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gustavsen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Personalized Medicine|July 27, 2022
Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United StatesMonica M Schroll, Arushi Agarwal, Olivia Foroughi, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Journal of Personalized Medicine|August 25, 2023
Barriers to g<i>BRCA</i> Testing in High-Risk HER2-Negative Early Breast CancerOlivia Foroughi, Shaheen Madraswala, Jennifer Hayes, et al.
Science Translational Medicine|August 2, 2013
Breaking a vicious cycleDaniel F Hayes, Jeff Allen, Carolyn Compton, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Personalized Medicine|July 27, 2022
Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United StatesMonica M Schroll, Arushi Agarwal, Olivia Foroughi, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Journal of Personalized Medicine|August 25, 2023
Barriers to g<i>BRCA</i> Testing in High-Risk HER2-Negative Early Breast CancerOlivia Foroughi, Shaheen Madraswala, Jennifer Hayes, et al.
Science Translational Medicine|August 2, 2013
Breaking a vicious cycleDaniel F Hayes, Jeff Allen, Carolyn Compton, et al.
Pageof 2